Global Vascular Stents Market Reach $4,230.0 mn by 2021


With the presence of key market companies such as Boston Scientific Corporation, Cordis Corporation, Cook Medical, C.R. Bard, Inc., Abbott Vascular, Inc., and W.L. Gore & Associates, the global vascular stents market is claimed to dominate the profit charts in the years to come.

Analysts at Zion Market Research claims: The global vascular stents market was capitalized at USD 2,907.1 Million in 2015 and is anticipated to create income of USD 4,230.0 Million by 2021, developing at a CAGR of 6.5% from 2015 to 2021.

Request Free Sample Report @

High Requirement For Minimally Invasive Operations All Over The World To Have A Towering Affect On Vascular Stents Market

The global vascular stents market is majorly boosted by rapid development in elderly population paired with high requirement for minimally invasive operations all over the world, as per the analysts at Zion Market Research. As per a study of WHO (World Health Organization), the amount of elderly population between 65–80 Years is expected to increase to 2 Billion from over 600 Million by 2050. Moreover, rising occurrence of cardiovascular diseases additionally drives the growth of global vascular stents market. Over a million individuals died from CVD (cardiovascular disease) in 2008 and the figure is expected to cross 23.3 Million by end of 2030, as per the WHO. In addition to this, the increasing awareness about the advantages of minimally invasive surgeries such as less bleeding and less damage to human tissue is further anticipated to prosper the growth of vascular stents market in the years to come. On the other hand, the high price of the vascular stent might hinder the vascular stents market development in the forecast period.

Nevertheless, technological enactment offering innovative products is expected to unlock up fresh development avenues in the forecast period for vascular stents market. For example, in August 2013, researchers in China and the U.S. have designed a biodegradable alloy (next-generation vascular stents) for employment in edical implants. The alloy, dubbed as JDBM, mixes neodymium, magnesium, zirconium, and zinc. JDBM degrades evenly in physiological circumstances so further operation to eliminate implants will not be required. The alloy balances degradation & durability and is ideal substance for medical devices that ease atherosclerosis, boosting the vascular stents market.

Inquiry more about this report @

Rapid Increment In Elderly To Maintain The Lead Of Vascular Stents Market In North America

In 2015, North America ruled the vascular stents market with more than 39% share of total income created. Europe was one more major region for vascular stents market and is likely to show substantial development in the years to come. Rapid increment in elderly population has boosted a steady rise in the number of patients needing therapy for peripheral vascular lesions in the U.S., elevating the demand of vascular stents market.

The global vascular stents market is segmented as follows:

By Product

  • Fem-pop artery stents
  • Iliac artery stents
  • Renal artery stents
  • Carotid artery stents
  • Others

This review is based on a report by Zion Market Research, titled “Vascular Stents Market”- Report at

By Region

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

Leave A Reply

Your email address will not be published.